These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 31264261

  • 1. Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside.
    Detlie TE, Lindstrøm JC, Jahnsen ME, Finnes E, Zoller H, Moum B, Jahnsen J.
    Aliment Pharmacol Ther; 2019 Aug; 50(4):397-406. PubMed ID: 31264261
    [Abstract] [Full Text] [Related]

  • 2. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
    Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, Thomsen LL, Carpenter TO, Weber T, Brandenburg V, Zoller H.
    JAMA; 2020 Feb 04; 323(5):432-443. PubMed ID: 32016310
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis.
    Schaefer B, Tobiasch M, Viveiros A, Tilg H, Kennedy NA, Wolf M, Zoller H.
    Br J Clin Pharmacol; 2021 May 04; 87(5):2256-2273. PubMed ID: 33188534
    [Abstract] [Full Text] [Related]

  • 5. Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer® ) versus ferric carboxy-maltose (Ferinject® ). A single center, cohort study.
    Mulder MB, van den Hoek HL, Birnie E, van Tilburg AJP, Westerman EM.
    Br J Clin Pharmacol; 2019 Feb 04; 85(2):385-392. PubMed ID: 30393904
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England.
    Iqbal TH, Kennedy N, Dhar A, Ahmed W, Pollock RF.
    J Med Econ; 2024 Feb 04; 27(1):392-403. PubMed ID: 38391240
    [Abstract] [Full Text] [Related]

  • 10. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
    Birgegård G, Henry D, Glaspy J, Chopra R, Thomsen LL, Auerbach M.
    Pharmacotherapy; 2016 Apr 04; 36(4):402-14. PubMed ID: 26927900
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status.
    Fang W, Kenny R, Rizvi QU, McMahon LP, Garg M.
    BMC Gastroenterol; 2020 Jun 10; 20(1):183. PubMed ID: 32522150
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
    Beigel F, Löhr B, Laubender RP, Tillack C, Schnitzler F, Breiteneicher S, Weidinger M, Göke B, Seiderer J, Ochsenkühn T, Brand S.
    Digestion; 2012 Jun 10; 85(1):47-54. PubMed ID: 22179489
    [Abstract] [Full Text] [Related]

  • 19. Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia.
    Mishra V, Gandhi K, Roy P, Hokabaj S, Shah KN.
    J Nepal Health Res Counc; 2017 Sep 08; 15(2):96-99. PubMed ID: 29016575
    [Abstract] [Full Text] [Related]

  • 20. Ferric Carboxymaltose: A Review in Iron Deficiency.
    Scott LJ.
    Drugs; 2018 Mar 08; 78(4):479-493. PubMed ID: 29532438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.